"Virginia Oncology Associates is an oncology and hematology practice of physicians, specializing in the diagnosis and treatment of cancer and blood disorders. With locations spanning the southeast region of Virginia and Northeastern North Carolina, we are able to extend services and treatments to patients, including medical oncology, radiation oncology, gynecologic oncology, hematology, diagnostics, clinical research, stem cell transplantation, genetic counseling, and psychosocial oncology."

During the past decade, Virginia Oncology Associates - Norfolk conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Virginia Oncology Associates - Norfolk" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 23 trials, followed by "SWOG Cancer Research Network" with 2 trials sponsored, "Astellas Pharma Global Development, Inc." with 1 trials sponsored, "Eastern Cooperative Oncology Group" with 1 trials sponsored and "Memorial Sloan Kettering Cancer Center" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Virginia Oncology Associates - Norfolk" #1 collaborator was "National Cancer Institute (NCI)" with 27 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Virginia Oncology Associates - Norfolk" are "Lung Cancer" (7 trials), "Lymphoma" (5 trials), "Colorectal Cancer" (4 trials), "Breast Cancer" (3 trials) and "Extragonadal Germ Cell Tumor" (2 trials). Many other conditions were trialed in "Virginia Oncology Associates - Norfolk" in a lesser frequency.

Most popular intervention types in "Virginia Oncology Associates - Norfolk" are "Drug" (23 trials), "Procedure" (7 trials), "Biological" (5 trials), "Radiation" (4 trials) and "Genetic" (2 trials). Other intervention types were less common.

The name of intervention was led by "gemcitabine hydrochloride" (6 trials), "carboplatin" (5 trials), "cisplatin" (5 trials), "cyclophosphamide" (4 trials) and "etoposide" (4 trials). Other intervention names were less common.

The vast majority of trials in "Virginia Oncology Associates - Norfolk" are 22 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Virginia Oncology Associates - Norfolk". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Virginia Oncology Associates - Norfolk, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Virginia Oncology Associates - Norfolk, 2 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".